STE - STERIS plc

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $269.50 DETAILS

Stock News

Reasons to Retain STE Stock in Your Portfolio for Now

STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.

May 22, 2026 09:15 AM • zacks.com

STERIS Q4 Earnings Call Highlights

STERIS NYSE: STE reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.

May 15, 2026 02:12 AM • marketbeat.com

STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading

STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.

May 12, 2026 11:25 AM • zacks.com

STERIS plc (STE) Q4 2026 Earnings Call Transcript

May 12, 2026 09:30 AM • seekingalpha.com

Steris (STE) Q4 Earnings and Revenues Miss Estimates

Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago.

May 11, 2026 03:12 PM • zacks.com

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

Medical equipment maker Steris forecast fiscal 2027 profit above Wall Street expectations on Monday, betting on strong demand ‌for its sterilization services despite narrowly missing estimates for fourth-quarter adjusted profit.

May 11, 2026 02:33 PM • reuters.com

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.

May 11, 2026 12:30 PM • globenewswire.com

STERIS Appoints Pierre Boulud to Board of Directors

DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are pleased to welcome Pierre to our Board,” said Mohsen Sohi, Chairman of STERIS.

May 07, 2026 12:30 PM • globenewswire.com

STERIS Announces Dividend of $0.63 per share

DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on June 26, 2026, to shareholders of record at the close of business on June 8, 2026.

May 05, 2026 12:30 PM • globenewswire.com

STERIS' Q4 Earnings on Deck: What's in Store for the Stock?

STERIS plc STE is scheduled to release fourth-quarter fiscal 2026 results on May 12, after market close.

May 04, 2026 08:20 AM • zacks.com

Critical Contrast: Bluejay Diagnostics (NASDAQ:BJDX) & STERIS (NYSE:STE)

Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) and STERIS (NYSE: STE - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Analyst Ratings This is a breakdown of recent ratings

Apr 26, 2026 10:22 PM • defenseworld.net

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

DUBLIN, IRELAND, April 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 fourth quarter and full year results at 9:00 a.m. ET on May 12, 2026.

Apr 21, 2026 12:30 PM • globenewswire.com

Rep. April McClain Delaney Buys Shares of Somnigroup International Inc. (NYSE:SGI)

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Somnigroup International Inc. (NYSE: SGI). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Somnigroup International stock on March 16th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of

Apr 09, 2026 10:03 PM • defenseworld.net

Rep. April McClain Delaney Buys Packaging Corporation of America (NYSE:PKG) Shares

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Packaging Corporation of America (NYSE: PKG). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Packaging Corporation of America stock on March 17th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000

Apr 09, 2026 10:02 PM • defenseworld.net

Tractor Supply (NASDAQ:TSCO) Stock Acquired Rep. April McClain Delaney

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Tractor Supply Company (NASDAQ: TSCO). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Tractor Supply stock on March 16th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of

Apr 09, 2026 10:02 PM • defenseworld.net

Is This the Right Time to Hold STERIS Stock in Your Portfolio?

STE rides on strong Healthcare and AST growth, but FX swings, tariffs, and rising costs cloud the outlook for investors.

Apr 08, 2026 07:51 AM • zacks.com

Aberdeen Group plc Buys 20,097 Shares of STERIS plc $STE

Aberdeen Group plc raised its stake in shares of STERIS plc (NYSE: STE) by 25.1% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 100,088 shares of the medical equipment provider's stock after purchasing an additional 20,097 shares

Apr 05, 2026 11:07 PM • defenseworld.net

Assenagon Asset Management S.A. Cuts Holdings in STERIS plc $STE

Assenagon Asset Management S.A. lowered its position in STERIS plc (NYSE: STE) by 94.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,742 shares of the medical equipment provider's stock after selling 312,165 shares during the period. Assenagon Asset Management S.A.'s holdings

Mar 29, 2026 11:14 PM • defenseworld.net

Virtus SGA International Growth Q4 2025 Portfolio Activity And Performance

Fast Retailing was a top contributor during the quarter, driven by strong execution across its global operations. Alibaba was a detractor during the quarter after the company reported mixed fiscal Q2 results. New positions were established in Sea Limited and Grab Holdings, while the portfolio's position in Atlassian was liquidated.

Mar 26, 2026 09:29 AM • seekingalpha.com

Cinctive Capital Management LP Has $4.61 Million Stake in STERIS plc $STE

Cinctive Capital Management LP lowered its position in STERIS plc (NYSE: STE) by 12.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,615 shares of the medical equipment provider's stock after selling 2,741 shares during the period. Cinctive Capital Management

Mar 16, 2026 12:31 AM • defenseworld.net

Price Targets